Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Recruiting"
topic_facet:"Phase: Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
PubPharm (5.968)
1
Cancer Molecular Screening and Therapeutics (MoST) Program Substudy Addendum 8 substudy 19: T-DM1 : Single arm, open label, signal seeking, phase IIa trial of the activity of Trastuzumab emtansine (T-DM1) in patients with tumours harbouring HER2 amplifications or mutations
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Effect of Zoledronic Acid or Denosumab on Bone Loss in Critically Ill Adults – A Randomised Controlled Trial : Effect of Zoledronic Acid or Denosumab on Bone Loss in Critically Ill Adults – A Randomised Controlled Trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Phase II basket study of an ARomatase inhibitor plus PI3KCA inhibitor or CDK4/6 inhibitor in women with hormone receptor positive recurrent/metastatic Gynaecological Neoplasms (PARAGON-II) : The activity and tolerability of Aromatase inhibitor plus PI3KCA inhibitor or CDK4/6 inhibitor in women with hormone receptor positive recurrent/metastatic gynaecological neoplasms (PARAGON-II) .
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
SHERLOCK: Phase 2 trial of sotorasib in combination with carboplatin-pemetrexed and bevacizumab-biosimilar as first line treatment for advanced non-squamous non-small cell lung cancerwith KRAS G12C mutation : SHERLOCK: Phase 2 trial of sotorasib in combination with carboplatin-pemetrexed and bevacizumab-biosimilar as first line treatment for advanced non-squamous non-small cell lung cancerwith KRAS G12C mutation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Cancer Molecular Screening and Therapeutics (MoST) Program Substudy Addendum 8 substudy 19: T-DM1 : Single arm, open label, signal seeking, phase IIa trial of the activity of Trastuzumab emtansine (T-DM1) in patients with tumours harbouring HER2 amplifications or mutations
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Effect of Zoledronic Acid or Denosumab on Bone Loss in Critically Ill Adults – A Randomised Controlled Trial : Effect of Zoledronic Acid or Denosumab on Bone Loss in Critically Ill Adults – A Randomised Controlled Trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Phase II basket study of an ARomatase inhibitor plus PI3KCA inhibitor or CDK4/6 inhibitor in women with hormone receptor positive recurrent/metastatic Gynaecological Neoplasms (PARAGON-II) : The activity and tolerability of Aromatase inhibitor plus PI3KCA inhibitor or CDK4/6 inhibitor in women with hormone receptor positive recurrent/metastatic gynaecological neoplasms (PARAGON-II) .
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
SHERLOCK: Phase 2 trial of sotorasib in combination with carboplatin-pemetrexed and bevacizumab-biosimilar as first line treatment for advanced non-squamous non-small cell lung cancerwith KRAS G12C mutation : SHERLOCK: Phase 2 trial of sotorasib in combination with carboplatin-pemetrexed and bevacizumab-biosimilar as first line treatment for advanced non-squamous non-small cell lung cancerwith KRAS G12C mutation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Propofol in cardiac surgery: ProMPT-2 : Efficacy of propofol-supplemented cardioplegia on biomarkers of organ injury in patients having cardiac surgery using cardiopulmonary bypass: Propofol cardioplegia for myocardial protection randomised controlled trial: the PROMPT2 Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
The development and evaluation of an artificial intelligence (AI) image recognition device to improve cervical pre-cancer screening and management in low- and middle-income countries : Systematic and Automated Visual Evaluation of Cervix
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[597]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Recruitment Status: Recruiting
Filter aufheben
Thema: Phase: Phase 2
Medienart
5.968
Aufsätze
5.968
E-Artikel
5.968
E-Ressourcen
Zeitschriftentitel
5.968
WHO International Clinical Trials Registry Plat...
Thema
5.968
610
Phase: Phase 2
Recruitment Status: Recruiting
5.560
Study Type: Interventional
356
Study Type: Observational
264
Medical Condition: ;Neoplasms
44
Medical Condition: Health Condition 1: B972- Co...
40
Medical Condition: Non-small cell lung cancer
30
Medical Condition: ;Diseases of the blood and b...
30
Medical Condition: esophageal cancer
30
Study Type: Treatment study
28
Medical Condition: ;Diseases of the digestive s...
28
Medical Condition: Breast cancer
26
Medical Condition: non-small cell lung cancer
22
Medical Condition: ;Diseases of the nervous system
22
Medical Condition: Gastric cancer
22
Medical Condition: colorectal cancer
20
Medical Condition: gastric cancer
18
Medical Condition: ;Diseases of the musculo-ske...
18
Medical Condition: Colorectal cancer
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5.200
2020-
768
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
5.890
Englisch
72
Unbestimmt
6
Sanskrit
Haven't found what you're looking for?
Wird geladen...